🌱 KidneyEnergy.com

← brief for 2026-10-15 · Slowing decline

Retatrutide treatment in streptozotocin-induced diabetic rats: renal inflammatory cytokines, HIF‑1α expression, and histopathological injury profile.

Article D Peer reviewed Preclinical

Key takeaways

This study tested a new drug called Retatrutide in rats with diabetes. It looked at how the drug affected kidney inflammation and damage. This was done in animals, not people yet.

Who did this work

Keskin U · Altın E · Özatik FY · Sezgin AK · Gündoğdu AÇ · Arı NS · Kara MK

Source

Article · PubMed, CKD progression and prevention · 2026 Oct 15
https://pubmed.ncbi.nlm.nih.gov/42878930/